Furthermore, ionic [64Cu]Cu2+ have also demonstrated improved diagnostic sensitivity in a recent study involving 50 patients with prostate cancer, with 82% detection rate compared to 74% using multiparametric MRI, which is the standard radiologic procedure, and 56% using [18F]-choline-PET, although the authors did not report comparisons with the more recently developed prostate-specific membrane antigen (PSMA)-based PET tracer [37]. This evidence concerns the gene FOLH1 and prostate cancer.